Literature DB >> 23621565

Albumin and α1-acid glycoprotein: old acquaintances.

Zemek Filip1, Korabecny Jan, Sepsova Vendula, Karasova Zdarova Jana, Musilek Kamil, Kuca Kamil.   

Abstract

INTRODUCTION: Albumin and α1-acid glycoprotein (AGP) are two of the most abundant proteins found in plasma. Their effect on the pharmacokinetic profile of exogenous compounds has major implications to clinical practice. Recent exploration into their possible role as diagnostic markers underlines their significance, and provides highlights their potential in medicinal applications. AREAS COVERED: This review summarizes the current understanding behind albumin and AGP. Specifically, the review focuses on their structure, physiological function, and their potential use in diagnostics as biomarkers. The article lists and describes the most common methods, with a specific focus on their use in drug design and clinical practice. EXPERT OPINION: Human serum albumin and AGP play a significant role in clinical practice. Research on human serum albumin and AGP, as potential diagnostic biomarkers, has been so far successful, with the development of novel diagnostic methods for detecting ischemia-modified albumin in cardiac ischemia patients. While research into this particular aspect is still in its infancy, future research should make things somewhat clearer and provide a better insight into the true potential of plasma proteins as a whole.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621565     DOI: 10.1517/17425255.2013.790364

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  8 in total

Review 1.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

2.  The 2-hydroxy-3-(4-aryl-1-piperazinyl)propyl Phthalimide Derivatives as Prodrugs-Spectroscopic and Theoretical Binding Studies with Plasma Proteins.

Authors:  Aleksandra Marciniak; Aleksandra Kotynia; Dominika Szkatuła; Edward Krzyżak
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

3.  Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.

Authors:  Yoshinao Ohbatake; Sachio Fushida; Tomoya Tsukada; Jun Kinoshita; Katsunobu Oyama; Hironori Hayashi; Tomoharu Miyashita; Hidehiro Tajima; Hiroyuki Takamura; Itasu Ninomiya; Masakazu Yashiro; Kousei Hirakawa; Tetsuo Ohta
Journal:  Clin Exp Med       Date:  2015-09-10       Impact factor: 3.984

4.  Chromatographic Studies of Protein-Based Chiral Separations.

Authors:  Cong Bi; Xiwei Zheng; Shiden Azaria; Sandya Beeram; Zhao Li; David S Hage
Journal:  Separations       Date:  2016-09-05

Review 5.  Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.

Authors:  Hifza Ahmed; Felix Bergmann; Markus Zeitlinger
Journal:  Antibiotics (Basel)       Date:  2022-07-08

6.  Acetylcholinesterase reactivators (HI-6, obidoxime, trimedoxime, K027, K075, K127, K203, K282): structural evaluation of human serum albumin binding and absorption kinetics.

Authors:  Filip Zemek; Jana Karasova Zdarova; Vendula Sepsova; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2013-08-02       Impact factor: 5.923

7.  The Interaction of Temozolomide with Blood Components Suggests the Potential Use of Human Serum Albumin as a Biomimetic Carrier for the Drug.

Authors:  Marta Rubio-Camacho; José A Encinar; María José Martínez-Tomé; Rocío Esquembre; C Reyes Mateo
Journal:  Biomolecules       Date:  2020-07-09

8.  New laboratory perspectives for evaluation of vivax malaria infected patients: a useful tool for infection monitoring.

Authors:  Eduardo Rodrigues Alves-Junior; Luciano Teixeira Gomes; Thaís Caroline Dallabona Dombroski; Andréia Ferreira Nery; Samuel Vandresen-Filho; Luciano Nakazato; Cor Jesus Fernandes Fontes; Fabrício Rios-Santos
Journal:  Braz J Infect Dis       Date:  2020-04-23       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.